Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

被引：0
|
作者：
Castrellon, Aurelio B.
Velez, Michel
Raez, Luis E.
Danenberg, Kathleen
Rabizadeh, Shahrooz
Usher, Joshua
Jaimes, Yolanda
Hunis, Brian
Bittencourt, Ana C.
Milillo, Adriana
Blaya, Marcelo
Habaue, Cheryl
Danenberg, Peter V.
机构：
[1] Mem Canc Inst, Hollywood, FL USA
[2] Liquid Genom Inc, Culver City, CA USA
[3] NantOmics, Culver City, CA USA
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-02-16
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer
    Stanek, Libor
    Gurlich, Robert
    Whitley, Adam
    Petra, Tesarova
    Music, Zdenek
    Novakova, Lucie
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (10): : 719 - 723
  • [42] Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer
    Kasabwala, Dimpal M.
    Cristofanilli, Massimo
    Alpaugh, R. Katherine
    Chumsri, Saranya
    Reduzzi, Carolina
    Tang, Cha-Mei
    Lapidus, Rena G.
    Del Priore, Giuseppe
    Williams, William V.
    Adams, Daniel L.
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Y Circulating exosomal PD-L1 to predict response with immunotherapy in patients with advanced cervical cancer
    Tang, Wenjie
    Guo, Qiufen
    Chen, Jinlong
    Wu, Qian
    Zhang, Tingting
    Wang, Qian
    Zhang, Xueliang
    Xie, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients
    Schwarzenbach, Heidi
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (7-8) : 423 - 429
  • [45] Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
    Kyoungmin Lee
    Jongwon Lee
    Jungmin Choi
    Sung Hoon Sim
    Jeong Eun Kim
    Min Hwan Kim
    Yeon Hee Park
    Jee Hyun Kim
    Su-Jin Koh
    Kyong Hwa Park
    Myoung Joo Kang
    Mi Sun Ahn
    Kyoung Eun Lee
    Hee-Jun Kim
    Hee Kyung Ahn
    Han Jo Kim
    Keon Uk Park
    In Hae Park
    Scientific Reports, 13
  • [46] A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma
    Steuer, Conor E.
    Griffith, Christopher C.
    Nannapaneni, Sreenivas
    Patel, Mihir R.
    Liu, Yuan
    Magliocca, Kelly R.
    El-Deiry, Mark W.
    Cohen, Cynthia
    Owonikoko, Taofeek K.
    Shin, Dong M.
    Chen, Zhuo G.
    Saba, Nabil F.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (03) : 710 - 716
  • [47] The clinical utility of detection of PD-L1 amplification with circulating cell- free DNA in patients with gastric cancer
    Fujita, Yuji
    Konishi, Hirotaka
    Shoda, Katsutoshi
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Komatsu, Shuhei
    Shiozaki, Atsushi
    Masuda, Kiyoshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Ichikawa, Daisuke
    Imoto, Issei
    Otsuji, Eigo
    CANCER SCIENCE, 2018, 109 : 1093 - 1093
  • [48] Relationship between PD-L1 Expression and EGFR/HER2 Signaling in Non-Small-Cell Lung Cancer
    Okita, R.
    Maeda, A.
    Shimizu, K.
    Nojima, Y.
    Saisho, S.
    Nakata, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2109 - S2109
  • [49] PD-L1 expression in patients with HER2-negative advanced breast cancer: A multicenter retrospective study
    Watanabe, Junichiro
    Takashi, Sugino
    Koji, Muramatsu
    Satoshi, Morita
    Yu, Hidaka
    Shogo, Nakamoto
    Mitsuya, Ito
    Shoichiro, Ohtani
    Masahiko, Ikeda
    ANNALS OF ONCOLOGY, 2022, 33 : S492 - S492
  • [50] PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients
    Julia Y. S. Tsang
    Wai-Ling Au
    Kwan-Yin Lo
    Yun-Bi Ni
    Thazin Hlaing
    Jintao Hu
    Siu-Ki Chan
    Kui-Fat Chan
    Sai-Yin Cheung
    Gary M. Tse
    Breast Cancer Research and Treatment, 2017, 162 : 19 - 30
12345